A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 08 Jan 2018
At a glance
- Drugs Enoxaparin sodium (Primary) ; Aspirin
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions; Therapeutic Use
- 08 Jan 2018 Results assessing safety and feasibility published in the JAMA Neurology
- 06 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 08 Apr 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018 as reported by ClinicalTrials.gov record.